Enhancer deregulation in cancer and other diseases
Abstract
Mutations in enhancer‐associated chromatin‐modifying components and genomic alterations in non‐coding regions of the genome occur frequently in cancer, and other diseases pointing to the importance of enhancer fidelity to ensure proper tissue homeostasis. In this review, I will use specific examples to discuss how mutations in chromatin‐modifying factors might affect enhancer activity of disease‐relevant genes. I will then consider direct evidence from single nucleotide polymorphisms, small insertions, or deletions but also larger genomic rearrangements such as duplications, deletions, translocations, and inversions of specific enhancers to demonstrate how they have the ability to impact enhancer activity of disease genes including oncogenes and tumor suppressor genes. Considering that the scientific community only fairly recently has begun to focus its attention on “enhancer malfunction” in disease, I propose that multiple new enhancer‐regulated and disease‐relevant processes will be uncovered in the near future that will constitute the mechanistic basis for novel therapeutic avenues.Keywords
Funding Information
- National Institutes of Health (4R00CA181506-02)
This publication has 151 references indexed in Scilit:
- Whole-genome analysis informs breast cancer response to aromatase inhibitionNature, 2012
- Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian GenomeCell, 2012
- Controlling Long-Range Genomic Interactions at a Native Locus by Targeted Tethering of a Looping FactorCell, 2012
- Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription RegulationCell, 2012
- Deletion of KDM6A, a Histone Demethylase Interacting with MLL2, in Three Patients with Kabuki SyndromeThe American Journal of Human Genetics, 2012
- Distinct roles of GCN5/PCAF‐mediated H3K9ac and CBP/p300‐mediated H3K18/27ac in nuclear receptor transactivationThe EMBO Journal, 2010
- Transcriptional Enhancers in Animal Development and EvolutionCurrent Biology, 2010
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genesNature, 2010
- A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease riskNature, 2005
- Expression of a β-globin gene is enhanced by remote SV40 DNA sequencesCell, 1981